ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025
Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS.
Amélie Poulin-Brière et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.